Posted on 8/15/18
Tecogen Inc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Tecogen Inc. in conjunction with their 2018 Q2 earnings call. 117READ FULL ARTICLE HERE
Posted on 8/15/18
Altimmune Provides Corporate Update
GAITHERSBURG, Md., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three and six months . . .
Posted on 8/14/18
U.S. News & World Report Names Hartford Hospital Best in Region
Hartford Hospital has been ranked #1 in the Hartfordregion and among the best in Connecticut for 2017-2018 by U.S. News & World Report. The annual U.S. . . .
Posted on 8/14/18
Austen Riggs Center Named a Top 10 "Best Hospital in Psychiatry" by U.S. News & World Report
The Austen Riggs Center has been recognized as a "Best Hospital" for 2018-19 by U.S. News & World Report, ranking #10 in Psychiatry nationwide. Unique among . . .
Posted on 8/14/18
REGENXBIO Announces Closing of Public Offering of Common Stock
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology . . .
Posted on 8/14/18
The Microbiome Therapeutics Innovation Group Announces Coalition Formation and Leadership Team
The Microbiome Therapeutics Innovation Group (MTIG) announced today the formation of their coalition which seeks to nurture innovation in microbiome therapeutics and microbiome-based products to address . . .
Posted on 8/14/18
HealthWell Foundation Opens Fund to Assist Patients Living with Gastric Cancer
The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has opened a new fund to provide copayment and premium assistance . . .
Posted on 8/14/18
CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in . . .
Posted on 8/13/18
Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
CHARLOTTESVILLE, Va., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a clinical-stage biotechnology company focused on improving patient outcomes in unmet medical needs . . .
Posted on 8/10/18
REGENXBIO Prices Public Offering
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology . . .
Posted on 8/10/18
Health-Care Company To Expand Henrico County Headquarters
A Henrico County-based health-care company, averhealth, plans to invest $325,000 to expand its headquarters and create 50 jobs.Founded in 1995, averhealth operates a network of substance . . .
Posted on 8/10/18
Howard University Hospital and Unity Health Care Announce a New Ward 7 Health Center
Howard University Hospital (HUH) and Unity Health Care, (Unity) today announced that Unity will open a new East of the River Health Center in early 2019. . . .
Posted on 8/10/18
Unity Health Care Announces Organizational Rebrand and Partnerships
Unity Health Care (Unity), the largest network of community health centers in Washington, D.C., launched a new brand campaign to highlight its dedication to inclusion and . . .
Posted on 8/9/18
Health IT Firms Insightin Health and Payspan Collaborate
GAITHERSBURG, Md. & ATLANTA--(BUSINESS WIRE)--Insightin Health, a provider of data-driven decision-making technology for healthcare member acquisition, retention and engagement, and Payspan, a leading provider of automated . . .
Posted on 8/9/18
Merkle and Cardinal Path to Partner on Delivery of Google Analytics 360
COLUMBIA, Md.--(BUSINESS WIRE)--Merkle, a leading technology-enabled, data-driven performance marketing agency, announced a formal agreement with Cardinal Path, an award-winning marketing analytics consulting firm and fellow member . . .
Posted on 8/9/18
Emergent BioSolutions To Acquire PaxVax For $270M
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to acquire PaxVax, a company focused on specialty vaccines that protect against . . .
Posted on 8/8/18
REGENXBIO Announces Proposed Public Offering Of Common Stock
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology . . .
Posted on 8/8/18
REGENXBIO Reports Second Quarter 2018 Financial and Operating Results
REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, . . .
Posted on 8/8/18
Emergent BioSolutions Makes Up for Last Quarter
Last quarter, Emergent BioSolutions' (NYSE:EBS) numbers looked downright ugly due to delayed timing of shipments of its products to the strategic national stockpile. With those shipments . . .
Posted on 8/7/18
Evolent Health Partners with Torrance Health IPA and Torrance Memorial Integrated Physicians
Evolent Health (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced it is providing . . .
Posted on 8/7/18
MacroGenics Provides Update on Corporate Progress
ROCKVILLE, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for . . .
Posted on 8/7/18
Rexahn Issues Mid-Year Shareholder Letter to Review Recent Progress and Clinical Plans
ROCKVILLE, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment . . .
Posted on 8/17/18
Interview with Paula Swain, EVP of Human Resources at Incyte Corporation - Part III
Brought to you by Newmark Knight Frank
Posted on 8/6/18
Rexahn Reports Second Quarter 2018 Financial Results
ROCKVILLE, Md., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment . . .
Posted on 8/5/18
DLA Piper Advises Liquidia Technologies in its $50M IPO
DLA Piper advised Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company, in its US$50 million initial public offering. The company is focused on the . . .
Washington DC
